Calliditas Therapeutics AB (publ) (CALT) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 6.96B |
| Enterprise Value | 6.96B |
| P/E Ratio | -23.94 |
| PEG Ratio | 0.41 |
| Price/Sales Ratio | 9.31 |
| Price/Book Ratio | 33.34 |
| Enterprise/Revenue | 9.32 |
| Enterprise/EBITDA | -30.57 |
| Fiscal Year | December 31, 2023 |
| Most Recent Quarter | June 30, 2024 |
| Profit Margin | -0.39 |
| Operating Margin | -0.32 |
| Return On Assets | -0.25 |
| Return On Equity | -0.85 |
| Revenue | 1.21B |
| Revenue/Share | 22.49 |
| Gross Profit | 1.13B |
| EBITDA | -367.8M |
| Net Income | -466.19M |
| Diluted EPS | -17.38 |
| Total Cash | 797.28M |
| Total Cash/Share | 18.14 |
| Total Debt | 1.01B |
| Total Debt/Equity | 2.92 |
| Current Ratio | 3.13 |
| Book Value Per Share | 6.24 |
| 52-Week Change | 129.16 |
| 52-Week High | 43 |
| 52-Week Low | 15.25 |
| Moving Average 50 Days | 39.65 |
| Moving Average 200 Days | 29.6 |
| Average Volume | 7,730 |
| Shares Outstanding | 53.69M |
| % Held by Institutions | 0.03 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |